Abstract:OBJECTIVE:The outbreak of novel coronavirus disease 2019 (COVID-19) imposed a substanal health burden in mainland China and remains a global epidemic threat. Our objectives are to assess the case fatality risk (CFR) among CO VID-19 patients detected in mainland China, stratified by clinical category and age group. METHODS:We collected individual information on laboratory-confirmed COVID-19 cases from publicly available official sources from December 29, 2019 to February 23, 2020. We explored the risk factors associated with mortality. We used methods accounting for right-censoring and survival analyses to estimatethe CFR among detected cases. RESULTS:Of 12,863 cases reported outside Hubei, we obtained individual records for 9,651 cases, including 62 deaths and 1,449 discharged cases. The deceased were significantly older than discharged cases (median age: 77 vs 39 years, p<0.001). 58% (36/62) were male. Older age (OR 1.18 per year; 95% CI: 1.14 to 1.22), being male (OR 2.02; 95% CI: 1.02 to 4.03), and being treated in less developed economic regions (e.g., West and Northeast vs. East, OR 3.93; 95 %Cl:1.74 to 8.85) were mortality risk factors. The estimated CFR was 0.89-1.24% among all cases. The fatality risk among critical patients was 2-fold higher than that among severe and critical patients, and 24-fold higher than that among moderate, severe and critical patients. CONCLUSIONS:Our estimates of CFR based on laboratory-confirmed cases ascertained outside of Hubei suggest that COVID-19 is not as severe as severe acute respiratory syndrome and Middle East respiratory syndrome, but more similar to the mortality risk of 2009 H1N1 influenza pandemic in hospitalized patients. The fatality risk of COVID-19 is higher in males and increases with age. Our study improves the severity assessment of the ongoing epidemic and can inform the COVID-19 outbreak response in China and beyond.

A Continuous Age-Specific Standardized Mortality Ratio for Estimating the Unascertained Rates in the Early Epidemic of COVID-19 in Different Regions

Estimating the case fatality ratio of the COVID-19 epidemic in China

A new method to calculate the instant case fatality rate of COVID-19 in Wuhan and Hubei of China

Towards Understanding the COVID-19 Case Fatality Rate

Using Markov Chain Monte Carlo methods to estimate the age-specific case fatality rate of COVID-19

Case Fatality Risk of the First Pandemic Wave of Coronavirus Disease 2019 (COVID-19) in China

Monitoring trends and differences in COVID-19 case-fatality rates using decomposition methods: Contributions of age structure and age-specific fatality

The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis

A Logistic Model for Age-Specific COVID-19 Case-Fatality Rates

Estimating the instant case fatality rate of COVID-19 in China

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

Determinants on COVID-19 Case Fatality Rates of Cities in China: A Logit-NB Hurdle Model Analysis

A scaling approach to estimate the COVID-19 infection fatality ratio from incomplete data

Case fatality risk of novel coronavirus diseases 2019 in China.

Risk Factors for Death Among the First 80 543 Coronavirus Disease 2019 (COVID-19) Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region

Age-specific mortality and immunity patterns of SARS-CoV-2

Estimation of Instant Fatality Rate of COVID-19 in Wuhan and Hubei Based on Daily Case Notification Data

Age-dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China

Estimation of standardized real-time fatality rate for ongoing epidemics

The spatial–temporal variations and influencing factors of COVID-19 case fatality rate: a worldwide study in 30 countries from February 2021 to May 2022

A Novel Approach to Calculate the Case Fatality Rate of COVID-19 in European countries